Regaal Resources Q1 FY27: Profit Up 47% to ₹13.3 Crore, Capacity Doubled
Regaal Resources reported a 47% year-on-year increase in Profit After Tax to ₹13.33 crore for Q1 FY27. Operating Income was ₹202.15 crore. The company doubled its maize crushing capacity to 1,650 TPD and commissioned new Liquid Glucose and Maltodextrin Powder facilities. Export contribution rose to 10.4%.
The doubling of crushing capacity, commissioning of new product facilities, and strong financial growth are significant developments that are expected to have a material impact on the company's future performance and market position.
The company reported significant year-on-year growth in profit and revenue, coupled with substantial capacity expansions and commissioning of new facilities, indicating positive operational and financial performance.
Regaal Resources Limited has announced its unaudited standalone financial results for the quarter ended June 30, 2026. The company reported a strong start to FY27 with healthy profitability growth.
Operating Income for the quarter stood at ₹202.15 crore (₹2,021.5 million). Value-Add increased by 30.3% year-on-year to ₹80.53 crore (₹805.3 million), with the Value-Add Margin expanding to 39.8%. Operating EBITDA grew by 26.6% year-on-year to ₹30.98 crore (₹309.8 million), and Profit After Tax (PAT) surged by 47.0% to ₹13.33 crore (₹133.3 million), with PAT margin improving to 6.6%.
The company also achieved significant operational milestones. Maize crushing capacity was doubled from 825 MT per day to 1,650 MT per day. Additionally, a new Liquid Glucose (LG) facility with a capacity of 180 MT per day and a Maltodextrin Powder (MDP) facility of 50 MT per day were commissioned, alongside an expansion of the captive co-generation power plant from 7.1 MW to 15.8 MW. These investments establish Regaal as the largest maize wet milling facility in Eastern India.
Exports' contribution more than doubled to 10.4% in Q1 FY27 from 4.9% in Q1 FY26. The management expects the benefits of the newly commissioned capacities to reflect from Q2 FY27 onwards. Future growth strategies include product expansion into derivative products like Dextrose Anhydrous, Dextrose Monohydrate, and Hydrol, as well as expanding the modified starch portfolio. Capex investment for these expansions is underway, with commissioning planned in phases through FY27.
What to do with a filing like this
Regaal Resources Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Regaal Resources Limited. Read the original for the full detail.